The National Agency for Pharmaceutical Products (ANPP) has announced its accession to the United States Pharmacopeial Convention (U.S. Pharmacopeia – USP) as a voting member. This development was outlined Monday in an official statement released by the Ministry of Pharmaceutical Industry.
This integration represents “a major milestone granting the institution access to a global platform uniting experts and organizations dedicated to advancing drug quality while ensuring public safety,” the ministry highlighted.
Furthermore, the move reflects “formal acknowledgment of Algeria’s ongoing efforts to elevate regulatory standards and safeguard public health,” the release added, noting that membership enables “Algeria, through its national agency, to actively contribute to global endeavors focused on setting and harmonizing pharmaceutical criteria, while creating broader avenues for technical exchange with international peers.”
Through this strategic alignment with the U.S. Pharmacopeia (USP), the National Agency for Pharmaceutical Products will maintain its drive toward continuous quality enhancement across Algeria’s domestic market. This measure will ensure “heightened health protection for patients while consolidating Algeria’s standing both regionally and globally,” according to ministry evaluations.
The ministry also noted that “the U.S. Pharmacopeia (USP) is a non-profit scientific organization whose primary mission centers on establishing universal criteria and mandatory benchmarks for the purity of medicines, dietary supplements, and raw active materials.” Standard benchmarks developed by this body maintain global recognition across the pharmaceutical sector.